CBM: Analysis & Opinions

  1. Earnings Beat at Actelion - Analyst Blog

    February 15, 2013
    Switzerland-based Actelion Ltd. (ALIOF) reported fourth quarter 2012 earnings of 47 cents per American Depository ...
  2. Dr. Reddy's Misses on Both Counts - Analyst Blog

    February 15, 2013
    Dr. Reddy's Laboratories (RDY) reported third quarter fiscal 2013 earnings per American Depositary Share (ADS) of 40 ...
  3. SGEN Narrows Loss, Sales Rise - Analyst Blog

    February 13, 2013
    Seattle Genetics, Inc. (SGEN) reported fourth quarter 2012 net loss per share of 9 cents, narrower than the Zacks ...
  4. Aegerion Prices Stock Offering - Analyst Blog

    January 14, 2013
    Aegerion Pharmaceuticals, Inc. (AEGR) recently provided more details on its public offering. The offering is ...
  5. Aegerion to Raise Funds - Analyst Blog

    January 11, 2013
    Aegerion Pharmaceuticals, Inc. (AEGR) recently announced its intention to raise funds through the issuance of its ...
  6. BioMarin Takes Over Zacharon - Analyst Blog

    January 10, 2013
    BioMarin Pharmaceutical Inc. (BMRN) recently acquired privately held biotechnology company, Zacharon ...
  7. Optimer's Dificid Sales Look Good - Analyst Blog

    January 09, 2013
    Optimer Pharmaceuticals Inc. (OPTR) recently announced its preliminary sales for the fourth quarter and full year ...
  8. Cambrex Corporation - Aggressive Growth

    October 04, 2012
    Cambrex Corporation (CBM) reached a new 52-week high of $13.44 on September 10, about a month after reporting strong ...
  9. Cambrex Signs New Supply Agreement - Analyst Blog

    August 17, 2012
    Cambrex Corporation (CBM) recently announced that it signed a key deal with an undisclosed new customer to supply an ...
  10. Cambrex Corp. - Momentum

    August 16, 2012
    Cambrex Corporation (CBM) has watched its earnings momentum jump since this life sciences company reported strong ...
Marketplace
Trading Center